Ginger & Chronic Pain: Fibromyalgia, Widespread Pain, and Quality of Life

Neurobiology of chronic pain and targets of ginger

Chronic pain involves two processes: (1) peripheral sensitization (hypersensitive nociceptors in the periphery) and (2) central sensitization (amplification of the pain signal in the spinal cord and brain). Ginger acts on both.

1. COX-2 inhibition and prostaglandins

Prostaglandins E2 (PGE2) sensitize peripheral and central nociceptors. Gingerols inhibit COX-2 → reduction of PGE2 in painful tissue and cerebrospinal fluid. Analgesic effect comparable to ibuprofen at an equivalent dose (study on joints-belgie">ginger osteoarthritis).

2. Reduction of substance P

Substance P is the main neuropeptide in pain transmission (C-fibers → dorsal horn). Shogaols reduce substance P release in the spinal dorsal horn through activation of opioid receptors (κ-opioids) — central analgesic effect. Spinal substance P reduction 35–45% in models of chronic pain.

3. TRPV1 desensitization

TRPV1 is the heat and pain detector of nociceptors. In chronic pain, TRPV1 is overactivated. Gingerols initially activate TRPV1 (mild burning sensation), after which the receptor desensitizes → reduction of sensitivity to thermal and mechanical pain.

4. Reduction of spinal and cerebral neuroinflammation

Chronic pain is associated with microglial activation in the spinal cord and brain. These activated microglia release TNF-α, IL-1β, IL-6 which amplify the pain signal. Gingerols partially inhibit this microglial activation by partially crossing the blood-brain barrier.

Fibromyalgia: clinical data

Chronic pain protocol

• 🌅 Morning: 1 shot of INTI ginger on an empty stomach
• ☀️ Afternoon: 1 shot of INTI ginger with a meal
• 🌙 Evening (optional for nocturnal pain): 1 shot before 5 PM
• Duration: at least 8 weeks for measurable effects on chronic pain

Anti-chronic-pain synergies

• Ginger + Turmeric (BCM-95 500 mg): Double COX-2 and NF-κB inhibition. Best-documented combination for chronic pain
• Ginger + Boswellia (600 mg): Boswellia inhibits 5-LOX (leukotriene pathway) which ginger partially inhibits. Triple action: COX-2 + 5-LOX + NF-κB
• Ginger + Magnesium (300 mg bisglycinate): Magnesium blocks NMDA receptors (receptors of central sensitization). Neurological complementarity
• Ginger + CBD (50–100 mg): Pharmacological interaction via endocannabinoid CB2 receptors (anti-inflammatory) and TRPV1. Possible analgesic synergy

FAQ